Lv37
380 积分 2023-08-18 加入
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
2天前
已完结
Trends in the drug target landscape for autoimmune diseases
4天前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
6天前
已完结
Cancer biomarkers discovered using pan-cancer plasma proteomic profiling
1个月前
已完结
Immune-mediated inflammatory disease therapeutics: past, present and future
1个月前
已完结
Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics
1个月前
已完结
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
2个月前
已完结
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
2个月前
已关闭
Navigating the complexities of drug development for inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
